News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

J. Jamie Alberty-Oller

Articles by J. Jamie Alberty-Oller

45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?

ByAmy Jeng,Cristina Solis-Pomales,Kseniya Roudakova,J. Jamie Alberty-Oller

May 26th 2024

Latest Updated Articles

45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?
May 26th 2024

Trending on CancerNetwork

Dose Modification Strategies in EGFR Mutated Metastatic Non-Small Cell Lung Cancer

I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer

Utilizing AI Algorithms to Inform Breast Cancer Chemoprevention Strategies

FDA Receives sBLA for Zenocutuzumab in Advanced NRG1+ Cholangiocarcinoma

Orca-T May Be “Important Step Forward” in Hematologic Malignancy Care